Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2021-01-01
|
| Series: | Emerging Microbes and Infections |
| Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2021.1896956 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849312954340605952 |
|---|---|
| author | Shan Su Yiming Shao Shibo Jiang |
| author_facet | Shan Su Yiming Shao Shibo Jiang |
| author_sort | Shan Su |
| collection | DOAJ |
| format | Article |
| id | doaj-art-1f1216b032fe47f2b439d00ffe5cf2b7 |
| institution | Kabale University |
| issn | 2222-1751 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Emerging Microbes and Infections |
| spelling | doaj-art-1f1216b032fe47f2b439d00ffe5cf2b72025-08-20T03:52:56ZengTaylor & Francis GroupEmerging Microbes and Infections2222-17512021-01-0110143944110.1080/22221751.2021.1896956Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variantsShan Su0Yiming Shao1Shibo Jiang2Key Laboratory of Medical Molecular Virology (MOE/MOH/CAM), School of Basic Medical Sciences, Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, Shanghai, People’s Republic of ChinaState Key Laboratory of Infectious Disease Prevention and Control (SKLID), National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (China CDC), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, People’s Republic of ChinaKey Laboratory of Medical Molecular Virology (MOE/MOH/CAM), School of Basic Medical Sciences, Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, Shanghai, People’s Republic of Chinahttps://www.tandfonline.com/doi/10.1080/22221751.2021.1896956 |
| spellingShingle | Shan Su Yiming Shao Shibo Jiang Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants Emerging Microbes and Infections |
| title | Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants |
| title_full | Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants |
| title_fullStr | Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants |
| title_full_unstemmed | Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants |
| title_short | Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants |
| title_sort | human challenge trials to assess the efficacy of currently approved covid 19 vaccines against sars cov 2 variants |
| url | https://www.tandfonline.com/doi/10.1080/22221751.2021.1896956 |
| work_keys_str_mv | AT shansu humanchallengetrialstoassesstheefficacyofcurrentlyapprovedcovid19vaccinesagainstsarscov2variants AT yimingshao humanchallengetrialstoassesstheefficacyofcurrentlyapprovedcovid19vaccinesagainstsarscov2variants AT shibojiang humanchallengetrialstoassesstheefficacyofcurrentlyapprovedcovid19vaccinesagainstsarscov2variants |